medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2015, Number 4

<< Back Next >>

Salud Mental 2015; 38 (4)

Propiedades psicométricas de la Escala Hospitalaria de Ansiedad y Depresión (HADS) en una población de pacientes oncológicos mexicanos

Galindo VO, Benjet C, Juárez GF, Rojas CE, Riveros RA, Aguilar PJL, Álvarez AMÁ, Alvarado AS

Language: Spanish
References: 37
Page: 253-258
PDF size: 244.66 Kb.


ABSTRACT

Background Symptoms of anxiety and depression are among the major mental health problems in cancer patients. These symptoms affect the quality of life and treatment adherence, and are associated with other symptoms and longer hospital stays. Valid and reliable screening instruments such as the Hospital Anxiety and Depression Scale (HADS), have made possible the detection of possible cases of depression and anxiety in medically ill patients. However, the psychometric properties of this instrument have not been documented in different types of cancer diagnoses in the Mexican population.
Objective To determine the psychometric properties of the HADS in a sample of patients with cancer from the Mexican population.
Method Four hundred patients from the National Cancer Institute participated, of which 226 were women (56.5%) and 174 men (43.6%), with a mean age of 47.4 ±14.1 years. Participants completed concurrently the HADS as well as the following inventories: 1. Beck Depression, 2. Beck Anxiety and 3. Distress Thermometer.
Results A factor analysis adjusted to two factors explained 48.04% of the variance, with 12 items loading on these two factors in a way similar to the original version. The internal consistency of the overall scale was satisfactory (α =0.86). Cronbach’s alphas for each subscale were .79 and .80. The concurrent validity assessed by way of correlations with concurrent measures showed significant associations (Pearson r=51-71, p‹0.05).
Discussion and conclusion The HADS has adequate construct validity, internal consistency and concurrent validity for its use in cancer patients from the Mexican population. The relevance of these results is a cost effective tool to provide timely mental health care early in oncological treatment for those in need. Detecting anxiety and depression symptoms through the HADS may benefit cancer patients by ensuring appropriate care that may increase their quality of life and treatment adherence, and reduce their hospital stays.


REFERENCES

  1. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C et al. Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001;10:19–28.

  2. Spiegel D. Cancer and depression. British J Psychiatry 1996;168(30):109– 116.

  3. Maté J, Hollenstein M, Gil F. Insomnio, ansiedad y depresión en el paciente oncológico. Psicooncología 2004;1(2):211-230.

  4. Derogatis LR, Morrow GR, Fetting J. The prevalence of psychiatric disorders among cancer patients. JAMA 1983:249:751-757.

  5. Jadoon NA, Munir W, Shahzad MA, Choudhry ZS. Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study. BMC Cancer 2010;10(594):1471-2407.

  6. Krauss HA, Hauss JP, Höckel M, Kortmann RD et al. Anxiety and depression in cancer patients compared with the general population. European J Cancer Care 2010;19:522–529.

  7. Massie MJ. Prevalence of depression in patients with cancer. J National Cancer Institute Monogr 2004;32:57–71.

  8. Henriksson MM, Isometsä ET, Hietanen PS, Aro HM et al. Mental disorders in cancer suicides. J Affect Disord 1995;36:11–20.

  9. Holland JC. Psycho-oncology. Nueva York: Oxford University Press; 1998.

  10. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107.

  11. Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiat Epidemiol 2010;45:355–361.

  12. Bottomley A. Depression in cancer patients: a literature review. Eur J Cancer 1998;7:181–191.

  13. Zigmond AS, Snaith RP. The hospital anxiety and depression Scale. Acta psychiatric Scandinavic 1983;67:361-370.

  14. Costantini M, Musso M, Viterbori P, Bonci F et al. Detecting psychological distress in cancer patients: validity of the Italian version of the hospital anxiety and depression Scale. Support-Care-Cancer 1999;7(3):121-127.

  15. Lisspers J, Nygren A, Soderman E. Hospital anxiety and depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997;96:281-286.

  16. Herrmann C. International experiences with the hospital anxiety and depression scale a review of validation data and clinical results. J Psychosomatic Research 1997;42(1):17-41.

  17. Carroll BT, Kathol RG, Noyes A. Screening for depression and anxiety in cancer patients using the hospital anxiety and depression Scale. General Hospital Psychiatry 1993;15:69-74.

  18. Chaturvedi S, Chandra K. Detection of anxiety and depression in cancer patients. NIMHANS J 1994;12:141-144.

  19. Bjelland I, Dahl AA, Haugc TT, Neckelmannd D. The validity of the hospital anxiety and depression Scale An updated literature review. J Psychosomatic Research 2002;52:69–77.

  20. Rico JL, Restrepo M, Molina M. Adaptación y validación de la escala hospitalaria de ansiedad y depresión (HAD) en una muestra de pacientes con cáncer del instituto nacional de cancerología de Colombia. Avances Medición 2005;3:73-86.

  21. Alexander S, Palmer C, Stone PC. Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Breast Cancer Res Treat 2010;122:573–578.

  22. Özalp E, Soygür H, Cankurtaran E, Turhan L et al. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psycho-Oncology 2008;17:668–675.

  23. Villegas Pérez GC. Reporte de experiencia profesional. Tesis de maestría en Psicología. México: Facultad de Psicología, UNAM; 2004.

  24. Rojas GC. Evaluar la validez de la escala de depresión geriátrica (GDS) y la escala de ansiedad y depresión para hospitales generales (HADS). Tesis de maestría. México: Fac de Medicina, Depto d Psiquiatría, UNAM; 1991.

  25. Whaley JA. Diagnóstico de ansiedad y depresión en pacientes quemados (Escala HAD como una herramienta diagnóstica). Tesis de maestría. México: Fac de Medicina, Depto de Psiquiatría, UNAM; 1992.

  26. López JC, Verónica V, Martínez A, Sierra AE et al. Exactitud y utilidad diagnóstica del hospital anxiety and depression Scale (HAD) en una muestra de sujetos obesos mexicanos. Rev Invest Clin 2002;54(5):403-409.

  27. Beck A, Ward C, Mendelson M, Mock J, Erbaungh J. An inventory for measuring depression. Archives General Psychiatry 1961;4:53-63.

  28. Jurado CS, Villegas E, Méndez SL, Rodríguez F et al. La estandarización del inventario de depresión de Beck para los residentes de la Ciudad de México. Salud Mental 1998;21(3)26-31.

  29. Suarez GVC. Validación de la Escala de automedición de depresión de Zung en adolescentes mexicanos de secundaria mexicanos. Tesis de licenciatura. México: Facultad de Piscología, UNAM; 1988.

  30. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consulting Clinical Psychology 1988;56:893-897.

  31. Robles R, Varela R, Jurado S, Páez F. Versión mexicana del inventario de ansiedad de Beck: Propiedades psicométricas. Revista Mexicana Psicología 2011;8:211-217.

  32. Holland JC. NCCN Practice guidelines for the management of psychosocial distress. Oncology 1999;13(15A):113-147.

  33. Almanza JJ, Rosario I, Pérez S. Traducción, adaptación y validación del termómetro de distréss en una muestra de pacientes mexicanos con cáncer. Rev Sanid Milit Mex 2008;62(5):209-217.

  34. Vázquez OG, Martínez MM, Ugalde SC, Castillo ER et al. Tamizaje de aspectos psico-oncológicos: validación de una lista de chequeo. Psicooncología 2013;10(2-3):407-415.

  35. Sellick SM, Edwardson AD. Screening new cancer patients for psychological distress using the hospital anxiety and depression scale. Psycho-Oncology 2007;16:534–542.

  36. Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: A Meta-analysis. J Behavioral Medicine 2010;29(1):17-27.

  37. Penedo FJ, Traeger L, Dahn J, Molton I et al. Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual hispanic men treated for localized prostate cancer: Results of a randomized controlled trial. International J Behavioral Medicine 2007;14(3):164–172.




2020     |     www.medigraphic.com